絞り込み

17092

広告

「"Rutkowski P "[Author]」の検索結果

365件中 61件~80件表示    検索結果をPubMedで見る PubMedで見る

Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries.

Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial.

Development and validation of a nomogram to predict recurrence and melanoma-specific mortality in patients with negative sentinel lymph nodes.

Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Grain-Boundary Interaction between Inconel 625 and WC during Laser Metal Deposition.

Genetic polymorphisms may influence the vertical growth rate of melanoma.

Subcutaneous metastases from melanoma: a discussion of clinical experience.

Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Amino acid profile after oral nutritional supplementation in hemodialysis patients with protein-energy wasting.

Salix viminalis L. - A highly effective plant in phytoextraction of elements.

Surgical management of metastatic gastrointestinal stromal tumour.

Outcome of First-Line Systemic Treatment for Unresectable Conventional, Dedifferentiated, Mesenchymal, and Clear Cell Chondrosarcoma.

Management of Renin-Angiotensin-Aldosterone System Blockade in Kidney Transplant Recipients.

Prevalence and Hypertension Treatment Schedule in Hemodialysis Patients and Renal Transplant Recipients in 2006 and 2014/2016.

Micropore Size Distribution and Surface Characteristics Co-influence on 4-Chlorophenol Adsorption Mechanism from Organic Solvents.

MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial.

Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series.

High baseline neutrophil-to-lymphocyte ratio predicts worse outcome in patients with metastatic BRAF-positive melanoma treated with BRAF and MEK inhibitors.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります